Activated CD56 + lymphocytes (NK+NKT) mediate immunomodulatory and anti-viral effects during Japanese encephalitis virus infection of dendritic cells in-vitro

Virology

Volumn 432, Issue 2, 2012, Pages 250-260

  Sooryanarain, Harini ^a   Ayachit, Vijay ^a   Gore, Milind ^a  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

Author keywords

Anti viral effect; Dendritic cells; Immunomodulation; Japanese encephalitis virus; NK and NKT cells

Indexed keywords

CD56 ANTIGEN; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL CONTACT; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIGENS, CD56; ANTIVIRAL AGENTS; CRICETINAE; DENDRITIC CELLS; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; HUMANS; IMMUNOMODULATION; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE; VIRUS REPLICATION;

JAPANESE ENCEPHALITIS VIRUS;

EID: 84865282276     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.05.013     Document Type: Article

References (56)

1. Aguilar P.V., Paessler S., Carrara S.A., Baron S., Poast J., Wang E., Moncayo C.A., Anishchenko M., Watts D., Tesh B.R., Weaver C.S. Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus. J. Virol. 2005, 79(17):11300-11310.
2. Aleyas A.G., George J.A., Han Y.W., Rahman M.M., Kim S.J., Han S.B., Kim B.S., Kim K., Eo S.K. Functional modulation of dendritic cells and macrophages by Japanese encephalitis virus through MyD88 adaptor molecule-dependent and -independent pathways. J. Immunol. 2009, 183(4):2462-2474.
3. Alter G., Malenfant J.M., Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J. Immunol. Methods 2004, 294(1-2):15-22.
4. Azeredo E.L., De Oliveira-Pinto L.M., Zagne S.M., Cerqueira D.I., Nogueira R.M., Kubelka C.F. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease. Clin. Exp. Immunol. 2006, 143(2):345-356.
5. Bakri Y., Schiffer C., Zennou V., Charneau P., Kahn E., Benjouad A., Gluckman J.C., Canque B. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 2001, 166(6):3780-3788.
6. Biron C.A., Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 2001, 13(4):458-464.
7. Byrnes A.A., Li D.Y., Park K., Thompson D., Mocilnikar C., Mohan P., Molleston J.P., Narkewicz M., Zhou H., Wolf S.F., Schwarz K.B., Karp C.L. Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C. J. Leukoc. Biol. 2007, 81(3):825-834.
8. Cao S., Li Y., Ye J., Yang X., Chen L., Liu X., Chen H. Japanese encephalitis virus wild strain infection suppresses dendritic cells maturation and function, and causes the expansion of regulatory T cells. Virol. J. 2011, 8:39.
9. Cavrois M., Neidleman J., Kreisberg J.F., Fenard D., Callebaut C., Greene W.C. Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J. Virol. 2006, 80(4):1992-1999.
10. CDC JEV fact sheet http://www.cdc.gov/ncidod/dvbid/jencephalitis/facts.htm.
11. Chang T.H., Liao C.L., Lin Y.L. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes. Infect. 2006, 8(1):157-171.
12. Chu J.J., Ng M.L. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway. J. Virol. 2004, 78(19):10543-10555.
13. Cooper A.M., Fehniger A.T., Fuchs A., Colonna M., Caligiuri A.M. NK cell and DC interactions. Trends Immunol. 2004, 25(1):47-52.
14. Dejnirattisai W., Duangchinda T., Lin C.L., Vasanawathana S., Jones M., Jacobs M., Malasit P., Xu X.N., Screaton G., Mongkolsapaya J. A complex interplay among virus, dendritic cells, T cells, and cytokines in dengue virus infections. J. Immunol. 2008, 181(9):5865-5874.
15. Engelmayer J., Larsson M., Subklewe M., Chahroudi A., Cox W.I., Steinman R.M., Bhardwaj N.B. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 1999, 163(12):6762-6768.
16. Erlanger E.T., Weiss S., Keiser J., Utzinger J., Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg. Infect. Dis. 2009, 15(1):1-7.
17. Ferlazzo G., Pack M., Thomas D., Paludan C., Schmid D., Strowig T., Bougras G., Muller W.A., Moretta L., Münz C. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Nat. Acad. Sci. U.S.A. 2004, 101(47):16606-16611.
18. Gerosa F., Baldani-Guerra B., Nisii C., Marchesini V., Carra G., Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002, 195(3):327-333.
19. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., Trinchieri G. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J. Immunol. 2005, 174(2):727-734.
20. Glass W.G., Lim J.K., Cholera R., Pletnev A.G., Gao J.L., Murphy P.M. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 2005, 202(8):1087-1098.
21. Glass W.G., McDermott D.H., Lim J.K., Lekhong S., Yu S.F., Frank W.A., Pape J., Cheshier R.C., Murphy P.M. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 2006, 203(1):35-40.
22. Granelli-Piperno A., Delgado E., Finkel V., Paxton W., Steinman R.M. Immature dendritic cells selectively replicate macrophagetropic (Mtropic) human immunodeficiency virus type 1, while mature cells efficiently transmit both M- and T-tropic virus to T cells. J. Virol. 1998, 72(4):2733-2737.
23. Grimm E.A., Mazumder A., Zhang H.Z., Rosenberg S.A. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 1982, 155:1823-1841.
24. Guermonprez P., Valladeau J., Zitvogel L., Théry C., Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu. Rev. Immunol. 2002, 20:621-667.
25. Hase T., Dubois R.D., Summers L.P., Downs B.M., Ussery A.M. Comparison of replication rates and pathogenicities between the SA 14 parent and SA 14-14-2 vaccine strains of Japanese encephalitis virus in mouse brain neurons. Arch. Virol. 1993, 130(1-2):131-143.
26. Ho L.J., Wang J.J., Shaio M.F., Kao C.L., Chang D.M., Han S.W., Lai J.H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 2001, 166(3):1499-1506.
27. Kedarnath N., Gore M.M., Dayaraj C., Sathe S.P., Ghosh N.S. Effect of various mitogens on the replication of Japanese encephalitis virus in human mononuclear leukocyte cultures. Indian J. Med. Res. 1986, 84(Sep):231-238.
28. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 2005, 79(17):11457-11466.
29. + T cell target specificities by intracellular delivery of viral proteins using the human immunodeficiency virus Tat protein transduction domain. J. Gen. Virol. 2004, 85(Pt. 2):471-482.
30. Lee C.J., Liao C.L., Lin Y.L. Flavivirus activates phosphatidylinositol 3-kinase signaling to block caspase-dependent apoptotic cell death at the early stage of virus infection. J. Virol. 2005, 79(13):8388-8399.
31. Li Y., Ye J., Yang X., Xu M., Chen L., Mei L., Zhu J., Liu X., Chen H., Cao S. Infection of mouse bone marrow-derived dendritic cells by live attenuated Japanese encephalitis virus induces cells maturation and triggers T cells activation. Vaccine 2011, 29(4):855-862.
32. Libraty D.H., Pichyangkul S., Ajariyakhajorn C., Endy T.P., Ennis F.A. Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 2001, 75(8):3501-3508.
33. Libraty H.D., Nisalak A., Endy P.T., Suntayakorn S., Vaughn W.D., Innis L.B. Clinical and immunological risk factors for severe disease in Japanese encephalitis. Trans. R. Soc. Trop. Med. Hyg. 2002, 96(2):173-178.
34. + mobilization, and enzyme release. J. Immunol. 1996, 156(1):322-327.
35. Maghazachi A.A., Al-Aoukaty A., Schall T.J. C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells-role for G proteins. J. Immunol. 1994, 153(11):4969-4977.
36. Mathur A., Bharadwaj M., Kulshreshtha R., Rawat S., Jain A., Chaturvedi U.C. Immunopathological study of spleen during Japanese encephalitis virus infection in mice. Br. J. Exp. Pathol. 1988, 69(3):423-432.
37. McRae B.L., Semnani R.T., Hayes M.P., van Seventer G.A. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. J. Immunol. 1998, 160(9):4298-4304.
38. Mogensen T.H., Paludan S.R. Molecular pathways in virus-induced cytokine production. Microbiol. Mol. Biol. Rev. 2001, 65(1):131-150.
39. Moretta A. The dialogue between human natural killer cells and dendritic cells. Curr. Opin. Immunol. 2005, 17:306-311.
40. Münz C., Steinman R.M., Fujii S. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. J. Exp. Med. 2005, 202(2):203-207.
41. Palucka A.K., Blanck J.P., Bennett L., Pascual V., Banchereau J. Cross-regulation of TNF and IFN-alpha in autoimmune diseases. Proc. Nat. Acad. Sci. U.S.A. 2005, 102(9):3372-3377.
42. Piccioli D., Sbrana S., Melandri E., Valiante N.M. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002, 195(3):335-341.
43. Ravi V., Parida S., Desai A., Chandramuki A., Gourie-Devi M., Grau E.G. Correlation of tumor necrosis factor levels in the serum and cerebrospinal fluid with clinical outcome in Japanese encephalitis patients. J. Med. Virol. 1997, 51(2):132-136.
44. Rinaldo R.C., Piazza P. Virus infection of dendritic cells: portal for host invasion and host defense. Trends Microbiol. 2004, 12(7):337-345.
45. Shresta S., Kyle J.L., Robert Beatty P., Harris E. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 2004, 319(2):262-273.
46. Silva M.C., Guerrero-Plata A., Gilfoy F.D., Garofalo R.P., Mason P.W. Differential activation of human monocyte-derived and plasmacytoid dendritic cells by West Nile virus generated in different host cells. J. Virol. 2007, 81(24):13640-13648.
47. Smit J.M., Moesker B., Rodenhuis-Zybert I., Wilschut J. Flavivirus cell entry and membrane fusion. Viruses 2011, 3(2):160-171.
48. Snijders A., Kalinski P., Hilkens C.M., Kapsenberg M.L. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 1998, 10(11):1593-1598.
49. Solomon T. Recent advances in Japanese encephalitis. J. Neurovirol. 2003, 9(2):274-283.
50. Solomon T. Flavivirus encephalitis. N. Engl. J. Med. 2004, 351(4):370-378.
51. Walzer T., Dalod M., Robbins S.H., Zitvogel L., Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005, 106(7):2252-2258.
52. Winter P.M., Dung M.N., Loan T.H., Kneen R., Wills B., Thu T.L., House D., White J.N., Farrar J.J., Hart A.C., Solomon T. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. J. Infect. Dis. 2004, 190(9):1618-1626.
53. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., Frankel S.S. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 2000, 6(7):816-820.
54. + T cells inhibit hepatitis C virus replication in human hepatocytes. Hepatology 2009, 49(3):753-762.
55. Zamai L., Ahmad M., Bennett I.M., Azzoni L., Alnemri E.S., Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 1998, 188(12):2375-2380.
56. Zhang M., Daniel S., Huang Y., Chancey C., Huang Q., Lei Y.F., Grinev A., Mostowski H., Rios M., Dayton A. Anti-West Nile virus activity of in vitro expanded human primary natural killer cells. BMC Immunol. 2010, 11:3.